Sartorius Aktiengesellschaft (SRT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT) has a cash flow conversion efficiency ratio of 0.049x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€188.90 Million ≈ $220.84 Million USD) by net assets (€3.89 Billion ≈ $4.55 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SRT net asset quality score to measure how much of total assets are equity-financed.
Sartorius Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Sartorius Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Sartorius Aktiengesellschaft earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Sartorius Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sartorius Aktiengesellschaft ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
XP Inc
F:XP9
|
-0.101x |
|
Quebecor Inc
TO:QBR-B
|
0.150x |
|
Healthcare Realty Trust Incorporated
NYSE:HR
|
0.012x |
|
Impulsora del Desarrollo y el Empleo en América Latina S.A.B. de C.V
MX:IDEALB-1
|
0.022x |
|
COM.INTL BK GDR S LE 10
F:CIN
|
-0.159x |
|
Indian Overseas Bank
NSE:IOB
|
-0.682x |
|
Hunan Yuneng New Energy Battery Material Co. Ltd. A
SHE:301358
|
N/A |
|
Thai Beverage Public Company Limited
F:T6W
|
0.035x |
Annual Cash Flow Conversion Efficiency for Sartorius Aktiengesellschaft (2013–2025)
The table below shows the annual cash flow conversion efficiency of Sartorius Aktiengesellschaft from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see SRT company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €3.87 Billion ≈ $4.52 Billion |
€837.00 Million ≈ $978.54 Million |
0.216x | -13.58% |
| 2024-12-31 | €3.90 Billion ≈ $4.56 Billion |
€976.20 Million ≈ $1.14 Billion |
0.250x | -15.90% |
| 2023-12-31 | €2.76 Billion ≈ $3.22 Billion |
€821.30 Million ≈ $960.19 Million |
0.298x | +7.84% |
| 2022-12-31 | €2.66 Billion ≈ $3.11 Billion |
€734.20 Million ≈ $858.36 Million |
0.276x | -45.60% |
| 2021-12-31 | €1.72 Billion ≈ $2.01 Billion |
€873.20 Million ≈ $1.02 Billion |
0.508x | +39.15% |
| 2020-12-31 | €1.40 Billion ≈ $1.64 Billion |
€511.52 Million ≈ $598.03 Million |
0.365x | +4.57% |
| 2019-12-31 | €1.08 Billion ≈ $1.26 Billion |
€377.19 Million ≈ $440.97 Million |
0.349x | +38.87% |
| 2018-12-31 | €973.39 Million ≈ $1.14 Billion |
€244.52 Million ≈ $285.87 Million |
0.251x | -1.89% |
| 2017-12-31 | €806.56 Million ≈ $942.95 Million |
€206.51 Million ≈ $241.43 Million |
0.256x | +10.70% |
| 2016-12-31 | €736.80 Million ≈ $861.40 Million |
€170.42 Million ≈ $199.24 Million |
0.231x | +18.96% |
| 2015-12-31 | €644.75 Million ≈ $753.78 Million |
€125.36 Million ≈ $146.56 Million |
0.194x | -25.39% |
| 2014-12-31 | €497.66 Million ≈ $581.82 Million |
€129.69 Million ≈ $151.62 Million |
0.261x | +13.63% |
| 2013-12-31 | €450.25 Million ≈ $526.39 Million |
€103.26 Million ≈ $120.72 Million |
0.229x | -- |
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more